IDH1 and central nervous system cancer: For gliomas, mutation at Arg132 of IDH1, and at the analogous codon Arg172 of IDH2, represents early initiating events that drive the evolution of low-grade glioma, including grade II to III astrocytoma and oligodendroglioma [16].